Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Decitabine (Dacogen) and Selinexor (KPT-330) in Acute Myeloid Leukemia

NCT02093403 is registered in ClinicalTrials.gov with Bhavana Bhatnagar as lead sponsor.

NCT NCT02093403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02093403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Decitabine (Dacogen) and Selinexor (KPT-330) in Acute Myeloid Leukemia
Lead sponsor
Bhavana Bhatnagar
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2014
Completion date
November 26, 2016
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, secondary acute myeloid leukemia, untreated adult acute myeloid leukemia